Industry Briefing
A single destination for timely, editor-curated robotics news from around the world.
Nvidia Launches Cosmos 3 Edge AI Model and Expands Physical AI Ecosystem in Japan
Nvidia has introduced its new AI model, Cosmos 3 Edge, aimed at enhancing physical AI applications in Japan. This model is designed to help systems perceive and navigate real-world environments, marking a significant step in Nvidia's strategy to penetrate the physical AI market. The expansion is part of CEO Jensen Huang's visit to Japan, where Nvidia is forming partnerships with local industrial leaders such as Fujitsu, Hitachi, and Kawasaki Heavy Industries. Huang emphasized the potential for Japan to reinvent its manufacturing sector for intelligent industries, highlighting the country's historical significance in modern manufacturing. Looking ahead, Nvidia is also targeting Japan's healthcare and biotechnology sectors, collaborating on initiatives like the Tokyo-1 AI drug discovery consortium. With Japan's AI market projected to reach $27.9 billion by 2029, Nvidia's efforts could significantly influence the landscape of AI adoption in the region. No further timeline was disclosed at the time of publication.
"BioGeometry" secures hundreds of millions in strategic funding to create a "microscopic world model" in life sciences.
AI-native biotechnology company BaiAo Geometry has successfully secured several hundred million yuan in strategic financing, with investments led by the Shanghai Biomedical Innovation Transformation Fund, Guoke Investment, Dacheng Wisdom, and Xinglian Capital, alongside follow-on investments from GaoRong Capital and the Index AI Industry Innovation Fund. The funds will primarily support the ongoing development of their life sciences micro-world model, GeoFlow, and the advancement of their proprietary drug pipeline. Artificial intelligence is rapidly evolving along two main trajectories: digital AI, represented by large language and multimodal models, and physical AI, exemplified by autonomous vehicles and humanoid robots. Life AI is emerging as a promising frontier, a sentiment echoed by leading global investors and scientists. BaiAo Geometry's GeoFlow model, launched in 2024, aims to understand and design molecular interactions at an atomic level, enabling the creation of novel molecules that have never existed in nature. The company has iterated GeoFlow multiple times, achieving significant advancements in protein structure prediction and de novo design capabilities. By applying Test-Time Scaling technology, BaiAo Geometry enhances the success rate of protein designs without the need for extensive retraining. This innovation allows for the rapid generation and optimization of high-affinity binding molecules, significantly reducing the time and cost associated with traditional drug discovery processes. BaiAo Geometry has established over 20 business development collaborations with domestic and international pharmaceutical companies, focusing on high-specificity antibody design and vaccine development. The company is currently working on the next iteration of GeoFlow, which aims to expand modeling from individual molecules to entire molecular systems, further revolutionizing drug development in the biotechnology sector.
Ayana Bio and Brevel net $1.25m grant to see if ‘illuminated fermentation’ can turbocharge plant cell culture
Ayana Bio, a biotechnology company, has secured a $1.25 million grant to explore the potential of "illuminated fermentation" in enhancing plant cell culture. The funding will support research focused on extracting valuable compounds from various plants, specifically targeting sage for rosmarinic acid, saffron for crocins, and marigold for zeaxanthin and lutein. This initiative aims to improve the efficiency and yield of plant-based production processes. The grant signifies a growing interest in innovative biotechnological methods to optimize the cultivation of high-value plant compounds, which are increasingly sought after in various industries, including pharmaceuticals and nutraceuticals.
Biomanufacturing & biologicals Deeptech EMEA FoodTech Nutrition & health Startups & funding
AI’s Next Revolution: Multiply Labs Is Scaling Robotics-Driven Cell Therapy Biomanufacturing Labs
A startup is collaborating with prominent cell therapy companies to revolutionize the manufacturing process within clean rooms by integrating robotics technology. This innovative approach is set to significantly lower production costs by over 70% and enhance output efficiency compared to traditional manufacturing systems. The initiative aims to address the growing demand for cell therapies, which require precise and sterile environments for production. By leveraging advanced robotics, the startup is not only streamlining operations but also positioning itself as a key player in the rapidly evolving biotechnology sector. This development is particularly timely, as the industry seeks to meet increasing patient needs while maintaining high-quality standards in cell therapy manufacturing.
NVIDIA BioNeMo Platform Adopted by Life Sciences Leaders to Accelerate AI-Driven Drug Discovery
NVIDIA has unveiled a significant expansion of its BioNeMo™ platform, an open development system designed to facilitate lab-in-the-loop workflows aimed at advancing AI-driven biology and drug discovery. This announcement was made today, reflecting NVIDIA's commitment to enhancing research capabilities in the life sciences sector. By integrating AI technologies with biological research, the platform aims to streamline the drug discovery process, allowing scientists to leverage advanced computational tools to accelerate their findings. The expansion is expected to foster collaboration among researchers and institutions, ultimately driving innovation in the field of biotechnology.
How to Choose the Right Hair Care Solution for You
As concerns about hair health grow, many individuals are turning to online reviews for guidance on effective hair care solutions. Common signs such as increased hair loss, a thinning ponytail, or an uncomfortable scalp often prompt people to seek remedies. This shift typically occurs when the issue becomes too significant to overlook, leading to late-night searches for products that promise results. The urgency to address these hair concerns reflects a broader trend in personal care, where consumers are increasingly relying on digital resources to make informed decisions about their hair care routines.
Health automation news beauty industry beauty technology biotechnology consumer health
How to expand the US economy
MIT faculty are exploring critical areas of innovation in their latest initiative, “Priority Technologies,” aimed at enhancing American prosperity and security for the present and future. The program, which focuses on identifying and developing technologies that can significantly impact the nation’s economic and strategic landscape, seeks to address pressing challenges and opportunities in various sectors. By fostering collaboration among researchers, industry leaders, and policymakers, the initiative aims to create a roadmap for technological advancements that will benefit the country in the coming decades. This effort underscores the importance of proactive engagement in technology development to ensure that the United States remains competitive and secure in an increasingly complex global environment.
Books and authors Faculty Innovation and Entrepreneurship (I&E) Technology and society Technology and policy Bioengineering and biotechnologyRobotics needs a service framework.
RSF defines a common language for robot service capability, lifecycle operations, certification pathways, and service-provider networks.
